Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain stent trial aims to ease pressure headaches and save sight

NCT ID NCT07561268

Not yet recruiting Disease control Sponsor: Acandis GmbH Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests a new stent called SILANCE for people with idiopathic intracranial hypertension (IIH), a condition where high pressure inside the skull causes severe headaches, ringing in the ears, and vision problems. The stent is placed in a narrowed vein in the brain to improve blood flow and lower pressure. The study will enroll 99 participants and follow them for 12 months to see if symptoms improve and if the procedure is safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SILANCE stent (a laser-cut, self-expanding metal tube placed in a narrowed brain vein)
What this could lead to
If it works, this could offer a new treatment option for people with IIH whose symptoms are not controlled by standard care, potentially reducing headaches, ringing in the ears, and vision loss.
What could go wrong
This is an early-stage, non-randomized trial with no control group, so results may not apply to all IIH patients. Risks include stroke, stent blockage, or the stent moving out of place.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC INTRACRANIAL HYPERTENSION (IIH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pseudotumor cerebri

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IDIOPATHIC INTRACRANIAL HYPERTENSION (IIH)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.